glp-1 weight loss stories Some people on weight-loss drugs are finding that the “magic” fades food cravings return and creeps back, often after a plateau around 9–18 months in. LINK IN Kelly's Journey: Conquering Weight Loss

Faculty Jill Fitzgerald, PharmD Former Director (retired) of Pharmacy Professional Development, University of Connecticut School of Pharmacy, Storrs, CT Sonya Kremenchugsky, PharmD Pharmacist, The Valley Hospital, Ridgewood, NJ Zachary McPherson, PharmD, Pharmacist, Walgreens, CT Morgan Miller, PharmD Dispensary Pharmacist Bluepoint Wellness Branford, CT Faculty Disclosure In accordance with the Accreditation Council for Pharmacy Education (ACPE) Criteria for Quality and Interpretive Guidelines, The University of Connecticut School of Pharmacy requires that faculty disclose any relationship that the faculty may have with commercial entities whose products or services may be mentioned in the activity

Carmot Therapeutics is developing three molecules that could help Roche foray into the obesity space

Greenwood, H

Shaharyar Khan, PhD, Chief Scientific Officer Number Of Employees: ~27 Stage: Private, Series B2 Financial Snapshot: Has raised $224M total across funding rounds, including a $132M Series B Notable Investors: RA Capital Management

Obesity is currently a growing public health concern (134) and as weight loss improves many obesity-related complications (135), there is a great deal of interest in developing weight-loss drugs